Rapid RV/LV vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Rapid RV/LV

by RapidAI

ClearRead CT

by Riverain Technologies

AI Verdict

Rapid RV/LV by RapidAI specializes in the rapid assessment of pulmonary embolism severity through automated right and left ventricle ratio measurements from CTPA scans. In contrast, ClearRead CT by Riverain Technologies focuses on enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. While both are FDA-cleared AI tools for cardiothoracic imaging, they address distinct clinical diagnostic needs, making them complementary rather than direct competitors.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is a rapid, automated assessment of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick, objective quantification of RV/LV ratios is essential for immediate patient triage and management decisions, helping to standardize severity assessment and reduce inter-rater variability.

View Rapid RV/LV →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the detection, characterization, and tracking of pulmonary nodules, as well as assessing coronary artery calcification from CT scans. This solution is particularly beneficial for lung cancer screening programs and routine thoracic imaging, where improved diagnostic accuracy, reduced reading times, and comprehensive nodule management over time are paramount.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Rapid RV/LV	ClearRead CT
Pricing	Contact vendor for pricing information.	Contact for pricing
Deployment	Unknown	On-premise (stand-alone server, virtual machine) and Cloud
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools prioritize integration and efficiency within radiology workflows. Rapid RV/LV offers rapid results within minutes and annotated images for quick assessment, while ClearRead CT boasts up to a 36% reduction in reading time and seamless PACS integration. Both aim to streamline the user experience effectively.

Clinical Value

ClearRead CT

ClearRead CT offers broader clinical utility by enhancing pulmonary nodule detection and coronary artery calcification analysis, with a reported 29% reduction in missed actionable nodules. Rapid RV/LV provides critical, rapid assessment of pulmonary embolism severity, but ClearRead CT's wider scope and quantified improvement in detection accuracy give it an edge in overall clinical impact.

Pricing & Value

Tie

Neither tool provides public pricing information, requiring direct contact with the vendor. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Rapid RV/LV

Rapid RV/LV explicitly states it is HIPAA compliant and has a BAA in place, alongside flexible on-premises or hybrid deployment options. While ClearRead CT operates with institutions like the VA, implying strong compliance, its BAA and HIPAA compliance are listed as 'likely' in the provided data, making Rapid RV/LV's explicit statements a clearer indicator of readiness.

Innovation

ClearRead CT

ClearRead CT features patented vessel suppression technology (Clear Visual Intelligence) to enhance nodule detection, which represents a distinct technological innovation in image processing. While Rapid RV/LV's automated RV/LV ratio measurement is valuable, ClearRead CT's core technological approach to improving image clarity for diagnosis appears more fundamentally innovative.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offered specific comparative details regarding the quality, accessibility, or comprehensiveness of support and documentation for either Rapid RV/LV or ClearRead CT. Both companies appear to offer standard enterprise-level customer support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Rapid RV/LV	ClearRead CT
Tool Name	Rapid RV/LV	ClearRead CT
Company	RapidAI (formerly iSchemaView)	RIVERAIN TECHNOLOGIES
Description	FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.	FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
Key Functionality	Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images showing ventricular measurements.	Pulmonary Nodule Detection, Patented Vessel Suppression, Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison, Coronary Artery Calcification (CAC) Scoring.
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Rapid RV/LV and ClearRead CT?

Rapid RV/LV by RapidAI is designed for the rapid assessment of pulmonary embolism (PE) severity by automatically measuring right and left ventricle ratios from CTPA scans. ClearRead CT by Riverain Technologies focuses on enhancing pulmonary nodule detection and coronary artery calcification (CAC) analysis in CT scans.

What specific measurements and analyses do these tools provide?

Rapid RV/LV provides AI-powered analysis of CTPA images to automatically measure right and left ventricle diameters and calculate the RV/LV ratio, with annotated images showing these measurements. ClearRead CT offers pulmonary nodule detection (solid, part-solid, ground glass), patented vessel suppression, nodule characterization and measurement (volume, diameter, location, type, depth), automated nodule tracking, and CAC scoring on ungated, non-contrast CTs.

How do these tools aim to improve diagnostic workflow or efficiency for physicians?

Rapid RV/LV provides rapid results within minutes of a scan and reduces inter-rater variability in PE severity assessment. ClearRead CT aims to reduce reading times by up to 36% and improve detection accuracy with a 29% reduction in missed actionable nodules.

What types of imaging scans are each tool designed to analyze?

Rapid RV/LV specifically analyzes CTPA (Computed Tomography Pulmonary Angiogram) scans for pulmonary embolism assessment. ClearRead CT enhances analysis in general CT scans for pulmonary nodule detection and performs coronary artery calcification scoring on ungated, non-contrast CTs.